Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer
Clinical trial NCT04917900 · UNKNOWN
Trial details
- NCT number
- NCT04917900
- Sponsor
- West China Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-08-30
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.